Surfactant Protein A (SP-A) ELISA

Surfactant Protein A ELISA Assay

$600.00

The Surfactant Protein A ELISA Assay is for the quantitative determination of Human SPA in serum, plasma and cell culture supernatant. The Surfactant Protein A ELISA Assay is intended for research use only and not for use in diagnostic or clinical procedures.

SKU: KBH7920 Categories: , ,

Surfactant Protein A ELISA Assay

The Surfactant Protein A ELISA Assay is For Research Use Only

Size: 12×8 wells
Sensitivity: 0.217ng/ml
Standard Range: 2-32ng/ml
Incubation Time: 70 minutes
Sample Type: Serum, cell culture supernatant and plasma
Sample Size: 40 ul
Alternative Name: SPA, SP-A

Assay Background

Surfactant protein A (SP-A), the most abundant apoprotein of pulmonary surfactant, is a hydrophilic hybrid molecule that belongs to the Ca2+-dependent animal lectin superfamily termed collectins. SP-A has multiple functions including participating in tubular myelin formation, regulating the recycling of surfactant lipids, and acting synergistically with the two lipophilic surfactant apoproteins to lower surface tension. In addition, SP-A plays a major role in host defense of the lung: it is an essential component of innate immunity and helps to activate acquired immunity. SP-A can act either as a proinflammatory or anti-inflammatory agent, increasing or decreasing production of inflammatory cytokines by inflammatory cells to either enhance pathogen killing or suppress inflammation under basal conditions. Finally, it has been shown that SP-A levels are altered during a number of disease states including adult respiratory distress syndrome (ARDS) and cystic fibrosis. Concomitantly, exposure of SP-A to severe inflammation may cause oxidation or nitration of the protein and result in inactivation. Inactivation of SP-A during disease states may therefore cause increased susceptibility to secondary lung infections.

Sample Preparation and Storage:
Specimens should be clear and non-hemolyzed. Samples should be run at a number of dilutions to ensure accurate quantitation.

  1. Extract as soon as possible after specimen collection as per relevant procedure. The samples should be tested as soon as possible after the extraction. Alternately the extracted samples can be kept in -20°C. Avoid repeated freeze-thaw cycles.
  2. Serum- Coagulate at room temperature for 10-20 minutes; centrifuge for 20-min at 2000-3000 rpm. Remove the supernatant. If precipitation appears, recentrifuge.
  3. Plasma- Use EDTA or citrate plasma as an anticoagulant, mix for 10-20 minutes; centrifuge for 15-min at 2000-3000 rpm. Remove the supernatant carefully. If precipitation appears, recentrifuge.
  4. Urine- Collect urine in a sterile container, centrifuge for 20-min at 2000-3000 rpm. Remove the supernatant. If precipitation appears, recentrifuge.
  5. Cell Culture Supernatant- Collect sample in a sterile container. Centrifuge for 20-mins at 2000-3000 rpm. Remove the supernatant carefully. When examining the components within the cell, dilute cell suspension with PBS (pH 7.2-7.4), if cell concentration is greater than 1 million/ml. Damage the cells by repeated freeze-thaw cycles to release intracellular components. Centrifuge for 20-min at 2000-3000 rpm. If precipitation appears, centrifuge again.
  6. Tissue Samples- Rinse tissues in PBS (pH 7.4) to remove excess blood thoroughly and weigh before homogenization. Mince tissues and homogenize them in PBS (pH7.4) with a glass homogenizer on ice. Thaw at 2-8°C or freeze at -20°C. Centrifuge at 2000-3000 RPM for approximately 20 minutes and collect the supernatant carefully.

Note: Grossly hemolyzed samples are not suitable for use in this assay

Related Products

Surfactant Protein D ELISA Assay
Human SP-D ELISA Kit
Mouse SP-D ELISA Kit

Additional Information

Assay Principle

The method employs sandwich ELISA technique. Monoclonal antibodies are pre-coated onto microwells. Samples and standards are pipetted into microwells and Human Surfactant Protein A, SPA present in the sample are bound by the antibodies. Biotin labeled antibody is added and followed by Streptavidin-HRP is pipetted and incubated to form a complex. After washing microwells in order to remove any non-specific binding, the substrate solution (TMB) is added to microwells and color develops proportionally to the amount of Human Surfactant Protein A, SPA in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.

Package Inserts

Please note: All documents above are for reference use only and should not be used in place of the documents included with this physical product. If digital copies are needed, please contact us.

Product Citations